Researchers developed and validated a new lung cancer prediction model, Sybil-Epi, by integrating clinical and epidemiologic data with a pre-existing model.
Radiological reporting is a central component of clinical decision-making and a patient safety-critical system. Radiology ...
Morning Overview on MSN
FDA-cleared tools speed lung cancer diagnosis and make treatment safer
Two FDA-cleared technologies are now available to speed the detection of suspicious lung nodules and reduce the physical ...
UCLA scientists have developed a simple and cost-effective blood test that, in early studies, shows promise in detecting ...
As lung cancer screening identifies an estimated 1.6 million suspicious lung nodules each year in the U.S. alone, physicians ...
"Lung cancer survival depends heavily on early detection," said Fernandez-Bussy, dean of research and a pulmonary and ...
UCHealth Parkview Medical Center in Pueblo is using new robotic technology for more accurate lung nodule biopsies. Here's what to know.
A retrospective pooled analysis of 1,100 patients demonstrates the Nodify CDT® test’s consistent clinical performance across nodule sizes and patient populations LOUISVILLE, Colo., March 20, 2026 ...
Lung cancer in general, and non-small cell lung cancer (NSCLC) in particular, is often asymptomatic in the early stages of the disease. When symptoms do occur in an early stage (e.g., endobronchial ...
In this case study, CyPath® Lung “Unlikely Malignancy” result supported physician’s decision to wait before ordering an invasive lung biopsy In a clinical study, noninvasive CyPath® Lung test ...
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today released a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results